Understanding AFib: AFib Awareness Month and Its Importance September is not just about the changing seasons or the back-to-school rush; it’s also a significant month for health awareness. Among the various health observances, AFib Awareness Month stands out, dedicated to raising awareness about atrial fibrillation (AFib)—a condition that affects millions of people worldwide. Understanding AFib, its risks, and how to manage it can be lifesaving. Here’s why AFib Awareness Month is so important and what you need to know about this condition. What is AFib?Atrial fibrillation, commonly known as AFib, is the most common type of irregular heart rhythm (arrhythmia). It occurs when the upper chambers of the heart (atria) beat irregularly and out of sync with the lower chambers (ventricles). This can lead to a range of symptoms, from a fluttering heartbeat and fatigue to more serious complications like stroke and heart failure.AFib can be intermittent or persistent, and while some people may not experience noticeable symptoms, others might feel palpitations, shortness of breath, or dizziness. The erratic rhythm can cause blood to pool in the heart, leading to the formation of blood clots. If a clot travels to the brain, it can cause a stroke, making AFib a serious condition that requires medical attention.Why AFib Awareness Month MattersThe observance of AFib Awareness Month in September is crucial for several reasons: Raising Awareness: Many people are unaware that they have AFib because it can be asymptomatic or mistaken for other conditions. Awareness campaigns help educate the public about the signs and risks associated with AFib, encouraging people to seek medical advice if they experience symptoms. Promoting Early Detection: Early detection of AFib is key to preventing serious complications like stroke. During this month, healthcare providers emphasize the importance of regular check-ups, especially for those at higher risk, such as older adults or individuals with underlying health conditions like high blood pressure, diabetes, or heart disease. Highlighting Treatment Options: AFib management has evolved significantly, with a range of treatment options available, from medications to control heart rate and rhythm, to procedures like cardioversion, catheter ablation, and the use of anticoagulants to reduce stroke risk. AFib Awareness Month is an opportunity to educate patients about these options and the importance of adhering to prescribed treatments. Encouraging Lifestyle Changes: Lifestyle modifications can play a critical role in managing AFib. This includes maintaining a healthy weight, reducing alcohol consumption, quitting smoking, managing stress, and staying physically active. Public health campaigns during AFib Awareness Month often focus on these preventive measures. Supporting Research and Innovation: The month also serves as a reminder of the ongoing need for research into AFib. Advances in medical technology, such as wearable devices that monitor heart rhythms, have the potential to revolutionize how AFib is detected and managed. By supporting research initiatives, we can hope for better treatments and perhaps even a cure in the future.

Exploring the 8 Key Objectives and Applications of Remote Patient Management Remote Patient Management (RPM) is more than just a technological innovation; it’s a game-changer in how we deliver cardiovascular care. The American College of Cardiology has highlighted eight critical objectives* that illustrate the transformative potential of RPM: 1. Increased Access to Care: RPM extends medical services to remote or underserved areas, ensuring that geographical barriers no longer impede quality healthcare.2. Prolonged Monitoring: By monitoring patients over an extended period, RPM enhances diagnostic accuracy and sensitivity, enabling more informed clinical decisions.3. Early Disorder Detection: RPM captures conditions that may go unnoticed during routine visits, such as arrhythmias or masked hypertension, offering a more comprehensive view of a patient’s health.4. Early Intervention: RPM allows for the early detection of disease deterioration, enabling timely management strategies that can prevent major cardiovascular events like heart attacks or hospitalizations.5. Lifestyle Improvements: Continuous monitoring through RPM supports treatment effectiveness, guiding adjustments that can significantly improve a patient’s lifestyle and overall well-being.6. Reduced Side Effects: By closely monitoring treatment responses, RPM helps minimize side effects and complications, optimizing patient outcomes.7. Enhanced Perioperative Outcomes: RPM improves outcomes around surgeries and procedures, ensuring safer discharges and reducing the risk of complications.8. Screening High-Risk Populations: RPM is crucial for screening and identifying under-detected health conditions in high-risk populations, enabling proactive interventions. As RPM continues to evolve, its integration into cardiology practice is not just a trend but a necessity. These objectives underscore the potential of RPM to revolutionize patient care, making it more proactive, personalized, and efficient. * »Remote Patient Management Workbook, » 2024, Das et al.

Revolutionizing Heart Failure Care: Introducing SignalHF AI Algorithm SignalHF*, an FDA-cleared AI algorithm, is becoming an essential ally for cardiac remote monitoring teams in a groundbreaking stride toward proactive healthcare management. With its capability to predict heart failure hospitalizations within 30 days, SignalHF stands at the forefront of a new era in cardiovascular care, enabling timely interventions. Heart failure, a chronic condition affecting millions globally, presents a significant burden on healthcare systems and individuals alike. Despite advancements in treatment modalities, preventing decompensations and hospitalizations remains a challenge. However, with the advent of artificial intelligence and predictive analytics, the landscape of heart failure management is undergoing a profound transformation. SignalHF, developed through rigorous research and testing, harnesses the power of machine learning to analyze diverse patient data and identify subtle patterns indicative of impending cardiac decompensations. By integrating various parameters such as physiological data, demographics, lead measurements, episodes, and therapies, SignalHF generates a comprehensive risk assessment tailored to each individual. SignalHF’s key strength lies in its proactive approach to healthcare. Rather than reacting to acute events, remote monitoring teams can intervene preemptively, potentially averting hospitalizations and improving patient outcomes. Its alert system is central to SignalHF’s functionality, which triggers notifications when a patient’s SignalHF score surpasses a predefined threshold. These alerts serve as a call to action for healthcare teams, prompting timely interventions such as medication adjustments, lifestyle modifications, or closer monitoring. By facilitating early interventions, SignalHF empowers clinicians to deliver personalized care and avoid adverse events. The launch of SignalHF heralds a new chapter in managing heart failure, characterized by proactive risk mitigation and personalized care delivery. As healthcare systems worldwide grapple with the challenges of rising chronic disease prevalence and constrained resources, innovative solutions like SignalHF are poised to transform patient care. *SignalHF is an FDA-cleared Class II medical device. See the instructions for use for more information.

Leveraging Emerging Science to Improve Patient Outcomes and Streamline Workflow A new scientific study, led by Dr. Niraj Varma and conducted by a team of leading experts, has cemented the importance of remote cardiac monitoring for Cardiac Implantable Electronic Devices (CIEDs). Published in Europace 2023, the paper « Remote monitoring of cardiac implantable electronic devices and disease management » outlines the remarkable benefits in clinical efficiency and patient safety, offering illuminating insights that underscore the value proposition of Implicity’s remote cardiac monitoring platforms. Dynamic and Tailored Patient Treatment Pathways The study underlines the transformative impact of remote monitoring in facilitating personalized, dynamic treatment pathways. This is particularly beneficial for assessing the success rates of Atrial Fibrillation (AF) therapies, a capability that resonates with Implicity’s mission to improve patient outcomes. Our AF Alert Management Algorithm, a CE-marked tool, works seamlessly with the device data and clinical information to offer tailored AF treatment. Enhancements in AF Detection and Anticoagulation Treatment The study impressively demonstrates that algorithms designed to scan all CIED transmissions for AF, enhanced AF detection sensitivity by 10%. In addition, these algorithms also improved the optimal treatment of oral anticoagulation by 6%. Implicity’s AF Alert Management Algorithm directly addresses these findings, focusing on analyzing device data like atrial burden raw data and clinical information such as anticoagulant medications. Our advanced algorithmic approach filters out irrelevant alerts while activating smart alerts for significant changes in AF treatment, streamlining anticoagulation treatment. Efficient Alert Management and Workflow OptimizationAn especially compelling point in the study is the application of an AI tool to filter AF alerts, resulting in an 84% reduction in notification burden without compromising patient safety. The work-saving benefit aligns closely with the capabilities of Implicity’s AF Alert Management Algorithm, which automates the labor-intensive process of AF monitoring.  Assisting Resource-Strained Hospitals The study suggests that third-party resources offer valuable support for healthcare institutions lacking the required staffing. Remote cardiac monitoring from Implicity extends your healthcare team and enables you to focus on critical cases by automating routine tasks. The landscape of cardiac care is undergoing a profound transformation, as illustrated by the study’s conclusion, even though remote monitoring of CIEDs has been the standard of care since 2015. New guidelines suggest clinically stable patients may only require in-office visits every 24 months or less frequently, introducing vast implications for workflow, reimbursement, and data management. The value of Implicity’s remote cardiac monitoring platforms extends beyond the technology’s robustness to the system’s adaptability and scalability. Drawing from the compelling evidence in this latest study, Implicity’s AF Alert Algorithm is a paragon of innovation optimized for efficiency and patient safety. Written by: Megan Grosz Read the Study References Niraj Varma, Frieder Braunschweig, Haran Burri, Gerhard Hindricks, Dominik Linz, Yoav Michowitz, Renato Pietro Ricci, and Jens Cosedis Nielsen. Remote monitoring of cardiac implantable electronic devices and disease management. Europace (2023) 25, 1–11 https://doi.org/10.1093/europace/euad233

Alert-Based Remote Monitoring for CIED Patients Since the 2015 Heart Rhythm Society’s expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices, remote monitoring for patients with (CIEDs) has been recognized as the gold standard.1 Connectivity became even more crucial during the Covid 19 pandemic, necessitating social distancing and limited in-person interactions; remote patient care had to shift from an optional, convenient solution to an essential requirement in ensuring continuous and effective healthcare provision.2 Though the pandemic may be behind us, remote monitoring continues to benefit clinics with device patients. Nearly ten years have passed since the release of the consensus in 2015. During this time, further research has reinforced the evidence that supports the benefits of remote monitoring to patients and providers. As a result, an updated statement has been issued recommending the implementation of third-party alert-based remote monitoring as part of the care provided to patients with cardiac implants.3 With only a small percentage (6.6%) of remote monitoring transmissions resulting in clinical action, this guideline was a welcomed addition, as most individual transmissions may not be crucial for immediate patient care and can easily overload providers with non-critical data.4 The biggest offender of non-critical transmissions from CIEDs is those of ILRS. A 2018-2019 study analyzed 26,713 consecutive patients equipped with Cardiac Implantable Electronic Devices (CIEDs); 18.8% had an implantable loop recorder (ILR). Of the 82,797 alerts sent, ILRs were responsible for a substantial 50.1%, demonstrating their significant role in the total alert volume. The staggering volume of transmissions and increasing alerts originating from ILRs underscore the necessity for a novel strategy in managing remote monitoring. This is crucial to decrease the time expended by clinical personnel in handling data that does not necessitate any clinical intervention.5 Due to this growing need, sophisticated remote cardiac monitoring (RCM) solutions have progressed from reporting generalized device transmissions to pertinent, actionable alerts. Alert-based monitoring digitally filters patient information, eliminating the deluge of data that comes with reporting on every transmission, regardless of severity to the patient. This approach to remote monitoring expends fewer clinic resources and provides a greater yield of actionable interventions.6 Continuous connectivity and clinic visits go hand in hand, with the latter done sparingly and when specific, actionable events are detected. This approach enhances the efficiency and responsiveness of patient care, ensuring timely medical intervention when necessary. Emerging as a leader in alert-based remote monitoring, Implicity’s intuitive cloud-based software enables healthcare providers to receive immediate alerts regarding any changes in patient conditions, thereby reducing the latency between the occurrence of a health event and its detection. By integrating directly with the manufacturer’s portals, the AI-powered solution ensures that pertinent data is readily accessible, enabling swift, data-driven decisions. This proactive approach to patient care fosters enhanced clinical outcomes, improves patient safety, and optimizes healthcare delivery by providing critical information as soon as it becomes available. Alert-based RCM not only benefits patients but also greatly improves the efficiency of device clinics. In the past, patients with CIEDs needed to visit clinics for check-ups regularly. This often meant taking time off work, waiting longer for appointments, and risking delayed detection of device-related problems. With alert-based RCM, device clinics can optimize workflow and streamline patient management. The constant remote monitoring of CIEDs ensures that clinics receive relevant data, eliminating unnecessary clinic visits. This enables healthcare providers to focus on patients requiring immediate intervention, enhancing overall clinic efficiency and providing better patient care. Patient connectivity is a key success factor of alert-based RCM, as it is a prerequisite for quick alert transmission. The 2023 Heart Rhythm Society’s expert consensus statement highlighted the importance of device clinics in managing patient connectivity. By identifying disconnected patients and automatically sending them an SMS, platforms like Implicity reduce the connectivity management effort for device teams while improving patient compliance. RCM solutions such as Implicity integrate seamlessly with existing healthcare systems, providing intuitive interfaces for clinicians and reducing the data management burden. By leveraging these resources, device clinics can allocate their resources effectively, providing personalized care to patients needing it while reducing the strain on the healthcare system. The advent of alert-based RCM systems has transformed the landscape of remote cardiac monitoring for patients with CIEDs and those who care for them. Third-party resources have emerged as invaluable tools for enhancing patient care and optimizing device clinic efficiency. By continuously monitoring crucial cardiac parameters and automatically alerting healthcare providers of abnormalities, alert-based remote monitoring can help ensure prompt intervention, reducing the risk of complications and hospital readmissions by up to 4%.7 By: Megan Grosz 1Slotwiner, Varma, et al. 2015 HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Published: May 13, 2015DOI:https://doi.org/10.1016/j.hrthm.2015.05.0082Varma N, Marrouche NF, Aguinaga L, et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic. J Am Coll Cardiol. 2020;76(11):1363-1374. doi:10.1016/j.jacc.2020.06.0193Ferrick AM, Raj SR, Deneke T, Kojodjojo P, Lopez-Cabanillas N, Abe H, Boveda S, Chew DS, Choi JI, Dagres N, Dalal AS, Dechert BE, Frazier-Mills CG, Gilbert O, Han JK, Hewit S, Kneeland C, Mirza SD, Mittal S, Ricci RP, Runte M, Sinclair S, Alkmim-Teixeira R, Vandenberk B, Varma N; Document Reviewers; Davenport E, Freedenberg V, Glotzer TV, Huang JL, Ikeda T, Kramer DB, Lin D, Rojel-Martínez U, Stühlinger M, Varosy PD. 2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic. J Arrhythm. 2023 May 19;39(3):250-302. doi: 10.1002/joa3.12851. PMID: 37324757; PMCID: PMC10264760.4Varma N, Epstein AE, Irimpen A, Schweikert R, Love C; TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122(4):325-332. doi:10.1161/CIRCULATIONAHA.110.9374095O’Shea CJ, Middeldorp ME, Hendriks JM, et al. Remote Monitoring Alert Burden: An Analysis of Transmission in >26,000 Patients. JACC Clin Electrophysiol. 2021;7(2):226-234. doi:10.1016/j.jacep.2020.08.0296Varma N, Love CJ, Michalski J, Epstein AE; TRUST Investigators. Alert-Based ICD Follow-Up: A Model of Digitally Driven Remote Patient Monitoring. JACC Clin Electrophysiol. 2021;7(8):976-987. doi:10.1016/j.jacep.2021.01.0087N, Marijon E, Abraham A, Ibnouhsein I, Bonnet J-L, Rosier A, Singh Heart Rhythm

Harnessing AI to Combat the Data Deluge from Implantable Loop Recorders The Intersection of AI and Remote Monitoring in Reducing Alert Burden is a Critical Path Forward in Cardiac Care. In the realm of cardiac healthcare, the role of remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is pivotal. However, the vast array of alerts generated by these devices poses a significant challenge to the effective and efficient management of cardiac patient care. A multicenter study examining the remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) has emphasized the significant alert burden associated with these devices. Over 82,000 alerts were generated over a 12-month period involving 26,713 patients, with implantable loop recorders (ILRs) notably overrepresented in these alert numbers.1 ILRs, often used for extended cardiac event monitoring, were responsible for over half of the total alerts. This disproportionate contribution may be due to the sensitivity of ILRs in capturing subclinical arrhythmias and the high frequency of recorded events. However, addressing the alert burden, particularly the volume generated by ILRs, requires efficient, intelligent solutions. One such solution comes from Implicity’s proprietary artificial intelligence algorithm: the ILR ECG Analyzer. This software medical device has been specifically designed to reduce the number of false positives in ECG recordings from patients implanted with Medtronic ILRs. Data shows that the ILR ECG Analyzer reduces the number of false positives by an impressive 79% while maintaining a high sensitivity of 99%. By effectively filtering out a significant portion of non-urgent or non-actionable alerts, this technology allows healthcare providers to better focus their attention and resources on truly critical patient and device events.2 In addition to improving the efficiency of RM, this reduction in alert burden can also potentially lead to better patient outcomes. As such, the ILR ECG Analyzer is a practical and beneficial application of AI in the healthcare technology sector, aligning with the broader scientific goal of optimizing the management and understanding of data generated through remote cardiac monitoring systems. By: Megan Grosz 1O’Shea CJ, Middeldorp ME, Hendriks JM, et al. Remote Monitoring Alert Burden: An Analysis of Transmission in >26,000 Patients. JACC Clin Electrophysiol. 2021;7(2):226-234. doi:10.1016/j.jacep.2020.08.0292https://academic.oup.com/eurheartj/article/42/Supplement_1/ehab724.0316/6393406?login=true Download PDF

From Data to Discovery: Remote Monitoring’s Critical Role in Research Data-driven insights from cardiac implantable electronic devices (CIEDs) can revolutionize research, leading to transformative discoveries in the healthcare field. In the ever-evolving healthcare field, the ability to collect and analyze data is paramount for healthcare providers and researchers. Cardiac implantable electronic devices (CIEDs) are vital in monitoring patients with cardiac conditions. Leveraging remote monitoring (RM) to harness the vast amounts of data generated by these devices offer benefits that are far-reaching. In addition to improving safety for the individual patient, RM is a powerful research tool that can deliver information from an enormous number of patients, providing the scientific community with important data regarding cardiac events safety.1 By collaborating with third-party remote monitoring platforms, researchers and clinicians can explore numerous research fields with greater precision and depth. They can investigate the efficacy of different treatment strategies, identify factors contributing to adverse events, and develop innovative interventions tailored to individual patients. For instance, through advanced data analytics, Implicity’s platform can identify various changes in a patient’s heart status, facilitating early detection of potential complications and timely interventions. Remote monitoring solutions like that offered by Implicity help to address the growing need to harness complex CIED data for clinical research by aggregating it into useful, actionable information for researchers. Raw Data for ResearchAccessing automatically synced raw data from CIEDs eliminates the need for manual data extraction and provides researchers with unprecedented immediacy in data availability. By obtaining raw data from CIEDs, healthcare providers can delve into the intricacies of device performance, patient-specific parameters, and other vital information. This access to data enables quick identification of trends, anomalies, and patterns, ultimately leading to timely interventions and improved patient outcomes. Normalized Patient Data Across ManufacturersOne of the challenges in cardiac research is the heterogeneity of CIEDs produced by different manufacturers. Each manufacturer may use proprietary data formats and structures, making comparing and analyzing data across different devices difficult. Implicity overcomes this hurdle by normalizing patient data across various CIED manufacturers. Harmonizing the data allows researchers to seamlessly compare and combine datasets for comprehensive analysis. This unified approach to data integration promotes collaboration, facilitates larger sample sizes, and enhances the statistical power of research studies. Customized Electronic Case Report Forms (eCRFs)The Implicity research feature provides customized electronic Case Report Forms (eCRFs) to facilitate data collection for research purposes. These eCRFs can be tailored to specific research protocols, ensuring standardized data collection across multiple sites. By streamlining data collection processes, the tool minimizes errors, enhances data quality, and simplifies data analysis. Researchers can easily capture the required variables, monitor study progress, and adjust and optimize data collection efficiency. Patient Consent TrackingRespecting patient privacy and ensuring informed consent is crucial in any research endeavor. Implicity incorporates a patient consent tracking feature that enables healthcare providers to manage and monitor patient consent in real-time. This ensures compliance with ethical and legal requirements, provides transparency to patients, and protects their rights. Researchers can easily track and manage consent status throughout the study, ensuring the privacy and autonomy of study participants. Leveraging data from CIEDs is crucial in advancing cardiac research. Partnering with platforms like Implicity opens new doors for exploring research fields, conducting clinical studies, and ultimately improving patient outcomes. By: Megan Grosz 1Lappegård KT, Moe F. Remote Monitoring of CIEDs-For Both Safety, Economy and Convenience? Int J Environ Res Public Health. 2021 Dec 28;19(1):312. doi: 10.3390/ijerph19010312. PMID: 35010572; PMCID: PMC8751026. Download PDF